Sernova Biotherapeutics (SEOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 07-2024 | 04-2024 | 01-2024 | 10-2023 | 07-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,879 | -14,499 | -7,211 | -28,913 | -20,451 |
| Depreciation Amortization | 270 | 153 | 77 | 330 | 244 |
| Accounts receivable | 215 | -94 | 264 | 170 | 296 |
| Other Working Capital | 7,086 | 4,836 | 3,456 | 3,697 | 4,061 |
| Other Operating Activity | 1,376 | 1,145 | 269 | 2,222 | 1,624 |
| Operating Cash Flow | $-10,933 | $-8,460 | $-3,144 | $-22,493 | $-14,228 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -74 | -74 |
| Sale Of Investment | 8,094 | 4,451 | 1,513 | 39,270 | 24,532 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -13,384 | N/A |
| Other Investing Activity | 26 | 26 | 26 | -13,410 | -26 |
| Investing Cash Flow | $8,119 | $4,477 | $1,539 | $25,787 | $24,431 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 12 | 12 | N/A | N/A | N/A |
| Other Financing Activity | 98 | 79 | -32 | 373 | 288 |
| Financing Cash Flow | $110 | $91 | $-32 | $373 | $288 |
| Beginning Cash Position | 6,369 | 6,424 | 6,455 | 2,800 | 2,829 |
| End Cash Position | 3,665 | 2,532 | 4,818 | 6,466 | 13,321 |
| Net Cash Flow | $-2,704 | $-3,892 | $-1,637 | $3,667 | $10,492 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,933 | -8,460 | -3,144 | -22,493 | -14,228 |
| Capital Expenditure | N/A | N/A | N/A | -74 | -74 |
| Free Cash Flow | -10,933 | -8,460 | -3,144 | -22,567 | -14,302 |